21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
#9902TRPM-2 antisense therapy
#9903Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Depression, Anxiety, and Neurodegenerative Disorders
#9904Treatment with opioid antagonists and mTOR inhibitors
#9905Use of a Combination of Udenafil and Alfuzosin or Oxybutynin for the Treatment of Overactive Bladder
#9906Hydroxamates as therapeutic agents
#9907COMPOSITIONS AND METHODS FOR TREATING CANCERS
#9908ANTITUMOR COMBINATION COMPRISING A MORPHOLINYL ANTHRACYCLINE DERIVATIVE AND DEMETHYLATING AGENTS
#9909Methods for Alzheimer's Disease treatment and cognitive enhancement
#9910INHIBITING ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
#9911Use and composition for treating dementia
#9912USE OF CHOLINESTERASE INHIBITORS FOR TREATING VASCULAR DEPRESSION
#9913COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#9914COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTERIODS
#9915COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#9916Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling
#9917SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME
#9918Methods of treating viral infections
#9919Combinations to improve animal health and performance
#9920Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
#9921Conjugate comprising P21 protein for the treatment of cancer
#9922Method for reducing pain with ziconotide and baclofen
#9923Method for reducing pain with ziconotide and morphine
#9924Methods for treatment of pain
#9925MODIFICATION OF FEEDING BEHAVIOUR
#9926COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS
#9927Methods of suppressing microglial activation
#9928Methods for modulating eicosanoid metabolism
#9929METHOD FOR TREATING NEURAL INJURIES
#9930CARDIOPLEGIC SOLUTION
#9931Chlorine dioxide solution composition
#9932ERYTHROCYTE ATP-RELEASE MODULATORS
#9933Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
#9934THERAPEUTIC AGENT FOR FIBROMYALGIA SYNDROME AND THERAPEUTIC AGENT FOR PAIN CAUSED BY MUSCLE SPASM
#9935HYALURONATE AND COLOSTRUM COMPOSITIONS AND METHODS OF USING THE SAME
#9936NOVEL DOSAGE AND FORMULATION
#9937ABUSE-RESISTANT OPIOID DOSAGE FORM
#9938Slow release magnesium composition and uses thereof
#9939NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#9940Method of treating malignant solid tumors using transcatheter arterial chemoembolization (TACE)
#9941METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
#9942Composition for treatment of hyperhidrosis
#9943NOVEL DOSAGE AND FORMULATION
#9944MULTILAYERED MODIFIED RELEASE FORMULATION COMPRISING AMOXICILLIN AND CLAVULANATE
#9945Tissue targeted antigenic activation of the immune response to treat cancers
#9946Therapeutic TB vaccine
#9947USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF ALPHA INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
#99485Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes
#9949Combination Of A Beta-Glucan And An EGF Receptor Antagonist For The Treatment Of Cancer And Infection
#9950Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
#9951Composition and method to alleviate joint pain
#9952Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
#9953Synbiotic mixture
#9954Use of probiotics
#9955NATURAL PRESERVATIVE BLEND
#9956METHOD AND COMPOSITION FOR THE REGENERATION OF TISSUE WITH THE AID OF STEM CELLS OR BONE MARROW CELLS
#9957METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY
#9958Bacteriophage-containing therapeutic agents
#9959Parvovirus cancer therapy and combination with chemotherapy
#9960RECOMBINANT NEWCASTLE DISEASE VIRUS
#9961Pharmaceutical composition for transnasal administration of peptide hormones or cytokines
#9962RABIES CURE
#9963Mobilization of hematopoietic stem cells
#9964COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION
#9965ELASTIN FOR SOFT TISSUE AUGMENTATION
#9966Compositions comprising E-selectin antagonists and uses therefor
#9967METHODS AND COMPOSITIONS FOR MODIFYING T CELL IMMUNE RESPONSES AND INFLAMMATION
#9968Use of oligomers of lactic acid in the treatment of gynaecological disorders
#9969Method and composition for the treatment of scars
#9970TREATMENT OF MELANOMA
#9971Combination Therapies for the Treatment of Obesity
#9972STABLE PHARMACEUTICAL AQUEOUS COMPOSITIONS
#9973Novel NIDDM Regimen
#9974Pharmaceutical composition
#9975METHODS FOR THE PREPARATION AND USE OF AQUEOUS SOLUTIONS OF MAGNESIUM VALPROATE HYDRATE AND L-CARNITINE
#9976USE OF A COMPOSITION COMPRISING AT LEAST ONE BETA-BLOCKER FOR THE TREATMENT OF SLEEP DISORDERS
#9977PTPH1 Inhibitors for the Treatment of Alzheimer's Disease
#9978Method of treating neuropathic pain
#9979Combination of a carbostyril and carnitine
#9980(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
#9981PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECEPTOR LIGANDS
#9982Methods and compositions for protecting and treating neuroinjury
#9983COMPOSITIONS FOR TREATING COGNITIVE DISORDERS
#9984METHOD OF TREATING MEN WITH METABOLIC AND ANTHROPOMETRIC DISORDERS
#9985Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer
#9986METHODS OF TREATING NEUROLOGICAL DISEASES USING DOCOSAHEXAENOIC ACID AND ARACHIDONIC ACID COMPOSITIONS
#9987SUPPORTING ACETYLCHOLINE FUNCTION
#9988Combinations of viscoelastics for use during surgery
#9989METHODS OF ADMINISTERING COMPOSITIONS INCLUDING IRON
#9990COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS
#9991Antiviral nucleosides
#9992Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof
#9993Inhibition of inflammation using antagonists of MUC1
#9994Antitumoral Treatments
#9995Synergistic 5′-methylthioadenosine combinations
#9996Pharmaceutical and cosmetic compositions including lactoferrin, ciclopirox, etidronic acid
#9997Methods for increasing absorption of peptides, peptidomimetics and other gastrointestinal transport protein substrates
#9998Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution
#9999NOVEL COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS.
#10000Method for the treatment of cancer
#10001Use of transplatin to prevent hearing loss
#10002Metal compounds, mixed or sulphated, as phosphate binders
#10003Solid preparation comprising alogliptin and metformin hydrochloride
#10004SYSTEM AND METHOD FOR FACILITATING HEMOSTASIS WITH AN ABSORBABLE SPONGE
#10005N-ACETYL CYSTEINE COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC EFFICACY OF ACETAMINOPHEN
#10006Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof
#10007Smoking cessation with body weight maintenance and nutritional supplement
#10008Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
#10009Methods and compositions for oral administration of proteins
#10010PHARMACEUTICAL COMPOSITIONS
#10011COMBINATION TREATMENT FOR NON-HEMATOLOGIC MALIGNANCIES
#10012Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators
#10013USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE
#10014TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
#10015Use of factor VIIa or factor VIIa equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ICH) in a selected subpopulation of ICH patients
#10016Antimicrobial Composition and Method for Use
#10017Compounds and method for reducing uric acid
#10018STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBRES
#10019USE OF PROBIOTICS AND FIBERS FOR DIARRHOEA
#10020Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci
#10021TOPICAL AGENT FOR DERMATOLOGICAL USE
#10022Vitamin formulation
#10023Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound
#10024Lipoxin A4 protection for cornea endothelial cells
#10025METHOD FOR TREATING PRURITUS BY ADMINISTERING FULLERENES
#10026DISINFECTANT AND METHOD OF MAKING
#10027METHODS OF TREATING COPD
#10028Medicament for the treatment of viral skin and tumour diseases
#10029METHODS FOR TREATING STRESS INDUCED EMOTIONAL DISORDERS
#10030Compositions and methods for treating fibroproliferative disorders
#10031COMPOSITION COMPRISING A COMBINATION OF AN AROMATASE INHIBITOR, A PROGESTIN AND AN OESTROGEN AND ITS USE FOR THE TREATMENT OF ENDOMETRIOSIS
#10032Lipid composition for improving brain function
#10033RESTORATIVE AGENT FOR ANTIBACTERIAL PEPTIDE PRODUCTION ABILITY
#10034COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
#10035Methods and compositions for increasing the anaerobic working capacity in tissues
#10036USES OF PDCD5 POLYPEPTIDE FOR TUMOR CHEMOTHERAPY AND ORGAN PROTECTION
#10037COMBINATION OF AN IRON CHELATOR AND AN IMMUNOSUPPRESSANT AND USE THEREOF
#10038Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides
#10039Anticancer Treatments
#10040PHARMACEUTICAL OR COSMETIC COMPOSITION AND USE OF A PKC INHIBITOR WITH AN MMP INHIBITOR FOR INHIBITING LANGERHANS' CELL MIGRATION
#10041Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
#10042LIQUID DIETARY SUPPLEMENT COMPOSITION
#10043Topical antifungal composition
#10044Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders
#10045Methods and compositions for treating thyroid-related medical conditions with reduced folates
#10046DULOXETIN COMPOSITION
#10047Herbal Composition for Osteoarthritis
#10048Method for Treating a Patient in Need of Aspirin Therapy
#10049SOLID PHARMACEUTICAL COMPOSITION COMPRISING A NON-PEPTIDE ANGIOTENSIN II RECEPTOR ANTAGONIST AND A DIURETIC
#10050SYNERGISTIC ANTIMICROBIAL PREPARATIONS CONTAINING CHLORITE AND HYDROGEN PEROXIDE
#10051Compositions and Methods of Topical Drug Delivery for the Treatment of Carpal Tunnel Syndrome
#10052PHARMACEUTICAL COMPOSITION FOR TREATING MALARIA
#10053COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR CONDITIONS
#10054Use of IL-1 antagonists to treat gout
#10055METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF ANTECEDENT HEMATOLOGIC DISORDERS
#10056Treatment Method
#10057Anti-FLT3 antibodies
#10058Toll-like receptor 3 antagonists
#10059Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation
#10060Combination Therapy to Treat Persistent Viral Infections
#10061Compositions and methods of tolerizing a primate to an antigen
#10062Biological bioadhesive compositions and methods of preparation and use
#10063tPA mutant in the treatment of acute brain injury and neurodegenerative disorders
#10064Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
#10065Cephalotaxine Alkaloid Compositions and Uses Thereof
#10066CREATINE-LIGAND COMPOUNDS AND METHODS OF USE THEREOF
#10067USE OF CELLS TO FACILITATE TARGETED DELIVERY OF NANOPARTICLE THERAPIES
#10068METHODS FOR TREATMENT AND PREVENTION OF MRSA/MSSA
#10069HUMAN ADIPOSE DERIVED INSULIN MAKING MESENCHYMAL STEM CELLS FOR TREATING DIABETES MELLITUS
#10070Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
#10071Methods for treating cancer with a recombinant MVA expressing HER-2
#10072Hepatitis C virus inhibitors
#10073METHODS AND MEANS FOR THE TREATMENT OF HPV INDUCED INTRAEPITHELIAL NEOPLASIAS
#10074Cyclosporin analogues
#10075Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
#10076METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#10077Ethyleneoxide butyleneoxide block copolymer compositions
#10078ROSACEA TREATMENTS USING POLYMETAL COMPLEXES
#10079Inhibitors of bruton's tyrosine kinase
#10080USE OF AN OZONE/OXYGEN MIXTURE AS PRIMARY ANTICANCER THERAPY THROUGH INTRAPERITONEAL INSUFFLATION
#10081Preparation and use of sleeve and micro-encapsulated topical analgesic patch for treating pain
#10082Non-sedating antihistamine injection formulations and methods of use thereof
#10083USE OF ANGIOGENESIS ANTAGONISTS IN CONDITIONS OF ABNORMAL VENOUS PROLIFERATION
#10084Membrane fusion inhibitor
#10085Marker for determination of sensitivity to anti-cancer agent
#10086Bioactive composition for the treatment of the HIV/AIDS, method for manufacturing and using the same
#10087Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
#10088CONCOMITANT DRUG
#10089Methods for treating ophthalmic, otic, or nasal infections
#10090METHOD FOR THE TREATMENT OF PSYCHIC DISORDERS
#10091Non-sedating antihistamine injection formulations and methods of use thereof
#10092TETRAHYDROPYRANONAPHTHYRIDINES DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC TREATMENT THEREOF
#10093Method and pharmaceutical to treat spinal discs
#10094Methods for Treatment of HIV or Malaria Using Combinations of Chloroquine and Protease Inhibitors
#10095AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#10096Method of treatment and compositions of D-chiro inositol and phosphates thereof
#10097SELECTIN LIGANDS USEFUL IN THE DIAGNOSIS AND TREATMENT OF CANCER
#10098NUTRITIOUS DRINK
#10099Composition and method for reducing food intake
#10100Topical compositions for anti-aging and methods of using same
#10101Composition for preventing and treating arthritic diseases
#10102Stabilized composition comprising at least one adrenergic compound
#10103METHOD OF INCREASING METABOLISM
#10104Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
#10105Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
#10106Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#10107Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue
#10108Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
#10109VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
#10110STYRENE MALEIC ANHYDRIDE BASED FORMULATION FOR MALE CONTRACEPTION AND PROSTATE CANCER
#10111Vaginal Suppository System and Method
#10112Ex vivo uses of immunostimulatory combinations
#10113HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN KRTCAP3 AND LIGANDS FOR THE PROTEIN KRTCAP3
#10114USES OF ANTI-CD40 ANTIBODIES
#10115DR4 ANTIBODIES AND USES THEREOF
#10116Uses of Mammalian Cytokine; Related Reagents
#10117Use of anti-IL-20 antibody for treating rheumatoid arthritis
#10118Methods of inhibiting tumor growth using TTK antagonists
#10119METHODS OF TREATING DISEASED TISSUE
#10120HYBRID TETNUS TOXOID PROTEINS THAT MIGRATE RETROGRADELY AND TRANSYNAPTICALLY INTO THE CNS
#10121COMPOSITION
#10122METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
#10123METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT
#10124Combinations of antibodies selective for DR5 and other therapeutic agents
#10125Therapeutic compounds
#10126THERAPEUTIC PREPARATIONS CONTAINING WHARTON'S JELLY
#10127Treatment of immunocompromised conditions
#10128Combinations of pyrazole kinase inhibitors
#10129PTEN Inhibitors Treat Neutropenia-Associated Pneumonia
#10130STEM CELLS FOR USE IN LOCATING AND TARGETING TUMOR CELLS
#10131Combination Therapies for the Treatment of Obesity
#10132Methods for treating restenosis using annexin A5
#10133Transluminal delivery of oncoltyic viruses for cancer therapy
#10134Pharmaceutical Formulations for Iontophoretic Delivery of an Immunomodulator
#10135Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
#10136Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
#10137USE OF OMEGA-3-FATTY ACID(S)
#10138Two container skin care product
#10139Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide
#10140PROPHYLACTIC OR THERAPEUTIC AGENT FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER
#10141ANTIMICROBIAL AND ANTIINFLAMMATORY COMPOSITION
#10142Compositions and methods for wound care
#10143Treatment method for anemia
#10144PHARMACEUTICAL COMPOSITION CONTAINING ALPHA-ADRENERGIC RECEPTOR ANTAGONIST AND AN ANTI-MUSCARINIC AGENT AND METHOD OF IMPROVING LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH PROSTATIC HYPERTROPHY
#10145PHARMACEUTICAL COMPOSITION
#10146Inhibitors of Bruton's tyrosine kinase
#10147Triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
#10148Quercetin-containing compositions
#10149Combination of azelastine and steroids
#10150Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function
#10151Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
#10152TOPICAL COMPOSITIONS AND THE USE THEREOF
#10153Supporting activities of daily living
#10154Antiaging chirally-correct mitoprotectant amino acid and peptide complexes
#10155Adrenomedullin production enhancer
#10156MEMORY IN SUBJECTS WITH MINI-MENTAL STATE EXAMINATION OF 24-26
#10157PREPARATION OF TERMINALLY-STERILIZED COLLAGEN THAT IS SOLUBLE AT NEUTRAL PH
#10158COMPOSITIONS AND METHODS FOR TREATING DIABETES USING LISOFYLLINE AND ISLET NEOGENESIS ASSOCIATED PEPTIDE
#10159Methods of Administering Anti-Inflammatory Cyclooxygenase-2 Selective Inhibitors
#10160SKIN SENSITIZER DELIVERY SYSTEM
#10161Ghrelin production promoter
#10162Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide
#10163METHODS OF TREATING TERM AND NEAR-TERM NEONATES HAVING HYPOXIC RESPIRATORY FAILURE ASSOCIATED WITH CLINICAL OR ECHOCARDIOGRAPHIC EVIDENCE OF PULMONARY HYPERTENSION
#10164PHARMACEUTICAL COMPOSITION
#10165Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site
#10166COMBINATION OF A RETINOID AND A PLATINUM ANTICANCER AGENT
#10167AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE
#10168Oral or enteral composition useful for recovery of physical functions
#10169METHODS OF TREATING TERM AND NEAR-TERM NEONATES HAVING HYPOXIC RESPIRATORY FAILURE ASSOCIATED WITH CLINICAL OR ECHOCARDIOGRAPHIC EVIDENCE OF PULMONARY HYPERTENSION
#10170Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#10171MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC
#10172Method for treating a patient at risk for developing an NSAID-associated ulcer
#10173Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
#10174BETAINE COMPOSITIONS
#10175Compounds and methods for treating influenza
#10176Pharmaceutical Tablet Containing A Liquid Filled Capsule
#10177Nanoparticles for protein drug delivery
#10178Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
#10179Compositions and methods for enhancing metal ion dependent drug therapies
#10180Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
#10181Method of improving immune function in mammals using lactobacillus strains with certain lipids
#10182Method of treating cancer with DLL4 antagonist and chemotherapeutic agent
#10183Anticancer Combination Therapies
#10184AXL antibodies
#10185TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH ANTIBODIES AGAINST CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4)
#10186Methods for treating cancer using combination therapy
#10187Cationic steroid antimicrobial compositions and methods of use
#10188NLRR-1 antagonists and uses thereof
#10189CRIPTO BINDING MOLECULES
#10190Methods and Devices for Treating Lung Dysfunction
#10191PREPARATION, USE OF PREPARATION FOR TREATMENT, AND METHOD OF TREATMENT OF INTESTINAL INFECTION
#10192Vasculostatic Agents and Methods of Use Thereof
#10193COMBINATION THERAPY FOR CHRONIC DERMAL ULCERS
#10194Antimicrobial lotion compositions
#10195ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE THEREOF
#10196Novel Combination of Therapeutic Agents
#10197COMPOSITIONS CONTAINING LACTOFERRIN, AND METHODS OF USING SAME TO PROMOTE GROWTH OF SKIN CELLS
#10198SHUTTER DEVICE FOR CAMERA
#10199Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#10200METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFECTION OR INFECTIOUS COLONIZATION OF THE EYELID, OCULAR SURFACE, SKIN OR EAR